Do you have trouble controlling your bladder?

Research studies are enrolling now!

Those who qualify may receive*:

  • Payment up to $300, which varies by study
  • Study-related care at no cost from local doctors
  • Study medication at no cost

Ready to get started? Click Here.

Overactive bladder is a medical condition that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may cause sufferers to accidentally leak urine. People with overactive bladder may feel embarrassed or fearful that they will have a bladder accident in public, which can limit their social activities. In addition, the frequent urge to urinate often wakes people up at night and disrupts restful sleep.

Both men and women may experience overactive bladder. Treatments include behavioral techniques and a range of medications designed to control and relax bladder muscles.

However, not everyone responds to these therapies, and new options are needed. You can help advance future treatment options by joining overactive bladder research studies. Right now, local doctors are evaluating a study medication for overactive bladder that isn’t available from your regular doctor, and you may be eligible to participate.

Take the next step to see if you qualify for local research studies for people with Overactive Bladder. But don’t delay — space is limited!

* In a research study, the participants may receive investigational study product or may receive an inactive substance, or placebo, depending on the study design. Participants receive study-related care from a doctor/research team for the duration of the study. Reasonable payments will be made for participation and the length of the study may vary.

Ready to get started?

Click Here.

or

Call 877-977-4744

How does it work?

1

Tell us a little bit about yourself

2

Answer some questions about your health

3

We will connect you to available studies in your area

Just takes a few minutes

AcurianHealth

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.